Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Anfibatide in Healthy Volunteers
NCT07887490Phase 1Not yet recruiting
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Nov 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in thrombosis comparing Recombinant Anfibatide Injection with Placebo (2 arms). Primary endpoint: Incidence and Severity of Treatment-Emergent Adverse Events at Day 8. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
anfibatide
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT07887490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07887490.